Method of inhibiting clostridium difficile by administration...

Details Method of inhibiting clostridium difficile by administration... Method of inhibiting clostridium difficile by administration...

A - Human Necessities

61

K

A61K 38/14 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2699550

Glycopeptide antibiotics, such as oritavancin, demonstrate significant activity against both a vegetative form of C. difficile and C. difficile spores. Methods for the treatment, prophylaxis and prevention of C. difficile infection and disease in animals, including humans, are described.

L'invention porte sur des antibiotiques glycopeptidique, tels que l'oritanvancine, qui ont une action significative sur à la fois une forme végétative de C. difficile et des spores de C. difficile. L'invention porte sur des procédés pour le traitement, la prophylaxie et la prévention d'une infection et d'une maladie par C. difficile dans des animaux, comprenant les êtres humains.

Affiliated with

Also associated with

Rating

Method of inhibiting clostridium difficile by administration... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of inhibiting clostridium difficile by administration..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting clostridium difficile by administration... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1867533